Pablo Berlanga-rekin lankidetzan egindako argitalpenak (4)

2023

  1. Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy

    Cancers, Vol. 15, Núm. 5

2021

  1. Pharmacogenetics in neuroblastoma: What can already be clinically implemented and what is coming next?

    International Journal of Molecular Sciences, Vol. 22, Núm. 18

2020

  1. MTHFR and VDR polymorphisms improve the prognostic value of MYCN status on overall survival in neuroblastoma patients

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

2019

  1. Pharmacogenetics implementation in the clinics: information and guidelines for germline variants

    Cancer Drug Resistance, Vol. 2, Núm. 1, pp. 53-68